论文部分内容阅读
BACKGROUND:Glypican-3(GPC-3)is frequently overexpressed in hepatocellular carcinoma(HCC).Recent studies have shown that GPC-3 is a highly efficient diagnostic biomarker of HCC and an indicator of poor prognosis in HCC patients who have undergone hepatectomy.However,its prognostic value in patients with HBV-associated HCC after liver transplantation(LT)is not clear.The present study is to evaluate the prognostic value of GPC-3 in patients with HBV-associated HCC after LT.